Urte Gayko - Nov 3, 2021 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Urte Gayko
Stock symbol
SMMT
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 04:17 PM
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +200K 200K Nov 3, 2021 Common Stock 200K $5.54 Direct F1, F3
transaction SMMT Stock Option (right to buy) Award +4.04K +2.02% 204K Nov 3, 2021 Common Stock 4.04K $5.54 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on November 3, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 3, 2022.
F2 The option was granted on November 3, 2021 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021.
F3 Not applicable.